Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors - PubMed (original) (raw)

Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors

P Mazzola-Pomietto et al. Psychopharmacology (Berl). 1996 Feb.

Abstract

Intraperitoneal administration of m-chlorophenylpiperazine (m-CPP) to Wistar rats produced hyperthermia with a peak effect at 30 min. Pretreatment with low doses of metergoline (5-HT1/5-HT2 antagonist), mesulergine and mianserin (5-HT2C/5-HT2A antagonists) blocked m-CPP-induced hyperthermia. Pretreatment with propranolol (beta-adrenergic receptor antagonist that also has binding affinity for 5-HT1A, 5-HT1B and 5-HT2B sites), yohimbine (alpha 2-noradrenergic antagonist that also has binding affinity for 5-HT2B sites), MDL-72222 or ondansetron (5-HT3 antagonists) did not attenuate m-CPP-induced hyperthermia. Only high doses of ketanserin, LY-53857 and ritanserin (5-HT2A/5-HT2C antagonists) as well as spiperone (5-HT1A/5-HT2A/D2 antagonist) attenuated m-CPP-induced hyperthermia. Daily administration of m-CPP produced complete tolerance to its hyperthermic effect by day 5. However, there was no cross-tolerance to 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI, a 5-HT2A agonist that also has high affinity for 5-HT2C receptors)-induced hyperthermia. m-CPP-induced increases in temperature were found to be significantly less in the Fawn-Hooded (FH) rat strain as compared to the Wistar rat strain; in prior studies, FH rats have been found to be subsensitive to other 5-HT2C-mediated pharmacologic responses. Altogether, these findings suggest that m-CPP-induced hyperthermia in rats is mediated by selective stimulation of 5-HT2C receptors.

PubMed Disclaimer

Similar articles

• Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
  Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Hill JL, Murphy DL. Mazzola-Pomietto P, et al. Psychopharmacology (Berl). 1995 Jan;117(2):193-9. doi: 10.1007/BF02245187. Psychopharmacology (Berl). 1995. PMID: 7753967
• Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
  Mazzola-Pomietto P, Aulakh CS, Tolliver T, Murphy DL. Mazzola-Pomietto P, et al. Psychopharmacology (Berl). 1997 Mar;130(2):144-51. doi: 10.1007/s002130050222. Psychopharmacology (Berl). 1997. PMID: 9106912
• Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
  Aulakh CS, Mazzola-Pomietto P, Wozniak KM, Hill JL, Murphy DL. Aulakh CS, et al. J Pharmacol Exp Ther. 1994 Jul;270(1):127-32. J Pharmacol Exp Ther. 1994. PMID: 8035308
• Novel discriminatory ligands for 5-HT2B receptors.
  Baxter GS. Baxter GS. Behav Brain Res. 1996;73(1-2):149-52. doi: 10.1016/0166-4328(96)00087-3. Behav Brain Res. 1996. PMID: 8788493 Review.
• Serotonergic regulation of associative learning.
  Harvey JA. Harvey JA. Behav Brain Res. 1996;73(1-2):47-50. doi: 10.1016/0166-4328(96)00068-x. Behav Brain Res. 1996. PMID: 8788476 Review.

Cited by

• 5-HT Receptors and Temperature Homeostasis.
  Voronova IP. Voronova IP. Biomolecules. 2021 Dec 20;11(12):1914. doi: 10.3390/biom11121914. Biomolecules. 2021. PMID: 34944557 Free PMC article. Review.
• 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.
  Martin CB, Martin VS, Trigo JM, Chevarin C, Maldonado R, Fink LH, Cunningham KA, Hamon M, Lanfumey L, Mongeau R. Martin CB, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(3):pyu056. doi: 10.1093/ijnp/pyu056. Int J Neuropsychopharmacol. 2014. PMID: 25522398 Free PMC article.
• A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance.
  Yanai H, Tomono Y, Ito K, Hirowatari Y, Yoshida H, Tada N. Yanai H, et al. Diabetes Metab Syndr Obes. 2009 Dec 18;3:1-6. doi: 10.2147/dmso.s8481. Diabetes Metab Syndr Obes. 2009. PMID: 21437070 Free PMC article.
• Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats.
  Hayashi A, Suzuki M, Sasamata M, Miyata K. Hayashi A, et al. Psychopharmacology (Berl). 2005 Mar;178(2-3):241-9. doi: 10.1007/s00213-004-2019-z. Epub 2004 Oct 21. Psychopharmacology (Berl). 2005. PMID: 15719229
• Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.
  Ricaurte GA, McCann UD. Ricaurte GA, et al. Neurotox Res. 2001 Jan;3(1):85-99. doi: 10.1007/BF03033232. Neurotox Res. 2001. PMID: 15111263

References

1. 1. J Clin Endocrinol Metab. 1985 Dec;61(6):1179-84 - PubMed
2. 1. Trends Pharmacol Sci. 1993 Jun;14(6):233-6 - PubMed
3. 1. J Pharm Pharmacol. 1984 Mar;36(3):197-9 - PubMed
4. 1. Br J Pharmacol. 1988 May;94(1):137-47 - PubMed
5. 1. Pharmacol Biochem Behav. 1988 Nov;31(3):567-71 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal